IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,861,951 | +112.8% | 1,760,625 | +92.5% | 0.02% | +128.6% |
| Q2 2023 | $37,531,085 | +9306.3% | 914,723 | +6864.5% | 0.01% | – |
| Q4 2021 | $399,000 | +69.1% | 13,134 | +122.2% | 0.00% | – |
| Q2 2021 | $236,000 | -99.4% | 5,911 | -99.3% | 0.00% | -100.0% |
| Q3 2020 | $41,234,000 | -59.6% | 868,993 | -49.8% | 0.01% | -60.9% |
| Q2 2020 | $102,141,000 | -45.8% | 1,732,364 | -56.5% | 0.02% | -54.0% |
| Q1 2020 | $188,422,000 | -53.7% | 3,985,217 | -40.9% | 0.05% | -41.2% |
| Q4 2019 | $407,034,000 | -12.3% | 6,737,856 | -13.0% | 0.08% | -19.0% |
| Q3 2019 | $464,023,000 | -5.7% | 7,745,339 | +1.1% | 0.10% | -3.7% |
| Q2 2019 | $492,192,000 | -19.6% | 7,658,199 | +1.6% | 0.11% | -21.6% |
| Q1 2019 | $611,947,000 | +48.4% | 7,539,076 | -1.2% | 0.14% | +35.0% |
| Q4 2018 | $412,317,000 | -14.0% | 7,627,005 | -17.9% | 0.10% | +2.0% |
| Q3 2018 | $479,443,000 | +24.4% | 9,295,165 | +0.5% | 0.10% | +17.4% |
| Q2 2018 | $385,379,000 | -12.2% | 9,248,361 | -7.1% | 0.09% | -13.1% |
| Q1 2018 | $438,770,000 | -20.0% | 9,953,942 | -8.7% | 0.10% | -18.2% |
| Q4 2017 | $548,120,000 | -5.3% | 10,897,033 | -4.5% | 0.12% | -9.0% |
| Q3 2017 | $578,810,000 | +8.3% | 11,416,359 | +8.7% | 0.13% | +5.6% |
| Q2 2017 | $534,236,000 | +42.0% | 10,502,010 | +12.2% | 0.13% | +38.5% |
| Q1 2017 | $376,295,000 | +31.2% | 9,360,553 | +56.1% | 0.09% | +26.4% |
| Q4 2016 | $286,787,000 | +153.1% | 5,995,932 | +93.9% | 0.07% | +157.1% |
| Q3 2016 | $113,316,000 | +1068.3% | 3,092,697 | +642.6% | 0.03% | +833.3% |
| Q2 2016 | $9,699,000 | -43.9% | 416,469 | -2.5% | 0.00% | -40.0% |
| Q1 2016 | $17,298,000 | -34.4% | 427,109 | +0.3% | 0.01% | -28.6% |
| Q4 2015 | $26,364,000 | – | 425,702 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |